Heath M and Raugi GJ |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus. |
2004 |
Adv Dermatol |
pmid:15544204
|
Gonin JM |
Maintenance immunosuppression: new agents and persistent dilemmas. |
2000 |
Adv Ren Replace Ther |
pmid:10782729
|
Ginocchio L et al. |
Refractory Ulcerated Necrobiosis Lipoidica: Closure of a Difficult Wound with Topical Tacrolimus. |
2017 |
Adv Skin Wound Care |
pmid:28914682
|
Balal M et al. |
Effects of cyclosporine and tacrolimus on maintenance therapy after renal transplantation. |
2004 May-Jun |
Adv Ther |
pmid:15509135
|
Diao H et al. |
Comparison of tacrolimus, fluorometholone, and saline in mild-to-moderate contact lens-induced papillary conjunctivitis. |
2012 |
Adv Ther |
pmid:22821643
|
Hon KL et al. |
Assessing itch in children with atopic dermatitis treated with tacrolimus: objective versus subjective assessment. |
2007 Jan-Feb |
Adv Ther |
pmid:17526458
|
Mancilla UE et al. |
Primary immunosuppression with tacrolimus in renal transplantation: a multicenter, open-label study. |
1999 Sep-Oct |
Adv Ther |
pmid:10915396
|
Lionetti P et al. |
Mucosal adaptation and destruction in response to lamina propria T cell activation in explants of human fetal intestine. |
1995 |
Adv. Exp. Med. Biol. |
pmid:8525974
|
Mori A et al. |
Enhanced production and gene expression of IL-5 in bronchial asthma. Possible management of atopic diseases with IL-5 specific gene transcription inhibitor. |
1996 |
Adv. Exp. Med. Biol. |
pmid:9095279
|
Shahidi M |
Thrombosis and von Willebrand Factor. |
2017 |
Adv. Exp. Med. Biol. |
pmid:27628010
|
Clemann N and Bechter R |
Effects of rapamycin and FK 506 on rat Sertoli cells in vitro. |
1998 |
Adv. Exp. Med. Biol. |
pmid:10026935
|
Thomson AW and Bonham CA |
Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection. |
1995 |
Adv. Exp. Med. Biol. |
pmid:7572394
|
Abramowicz D et al. |
Immunosuppressive strategies in renal transplantation at the beginning of the third millennium. |
2000 |
Adv. Nephrol. Necker Hosp. |
pmid:11068631
|
Li PK et al. |
The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506. |
1990 |
Adverse Drug React Acute Poisoning Rev |
pmid:1703724
|
Doren EL and Aya-ay ML |
Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids. |
2014 |
Aesthet Surg J |
pmid:24448967
|
Bolton C |
The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE). |
1992 |
Agents Actions |
pmid:1380765
|
Griffiths RJ et al. |
Characterisation of passively transferred antigen arthritis induced by methylated bovine serum albumin in the rat: effect of FK 506 on arthritis development. |
1992 |
Agents Actions |
pmid:1384284
|
MartÃn-Cano FE et al. |
mTOR pathway and Ca²⺠stores mobilization in aged smooth muscle cells. |
2013 |
Aging (Albany NY) |
pmid:23661091
|
Sekigawa I et al. |
FK506 can inhibit apoptotic cell death induced by the HIV-1 envelope glycoprotein gp120. |
1994 |
AIDS |
pmid:7531458
|
Antonini TM et al. |
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation. |
2015 |
AIDS |
pmid:25387314
|
Florio G et al. |
The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils. |
2000 |
AIDS |
pmid:10853974
|
Nowak P et al. |
Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. |
2003 |
AIDS Res. Hum. Retroviruses |
pmid:12581512
|
Sklar EM |
Post-transplant neurotoxicity: what role do calcineurin inhibitors actually play? |
2006 |
AJNR Am J Neuroradiol |
pmid:16971594
|
Bargalló N et al. |
Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. |
2000 |
AJNR Am J Neuroradiol |
pmid:10730638
|
Bartynski WS et al. |
Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. |
2001 Nov-Dec |
AJNR Am J Neuroradiol |
pmid:11733324
|
Bartynski WS et al. |
Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. |
2004 |
AJNR Am J Neuroradiol |
pmid:14970028
|
Bartynski WS et al. |
Posterior reversible encephalopathy syndrome after solid organ transplantation. |
2008 |
AJNR Am J Neuroradiol |
pmid:18272559
|
Schuuring J et al. |
Severe tacrolimus leukoencephalopathy after liver transplantation. |
2003 Nov-Dec |
AJNR Am J Neuroradiol |
pmid:14625238
|
Oliverio PJ et al. |
Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. |
2000 |
AJNR Am J Neuroradiol |
pmid:10954277
|
Appignani BA et al. |
Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. |
1996 |
AJR Am J Roentgenol |
pmid:8623651
|
Landy J and Hart AL |
Commentary: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23336680
|
Hirai F et al. |
Letter: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23336690
|
Schmidt KJ et al. |
Letter: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - authors' reply. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23336691
|
Baumgart DC et al. |
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12755840
|
Srinivas NR |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589592
|
BenÃtez C et al. |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589580
|
Yamamoto T et al. |
Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26762838
|
Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Travis S |
Review article: saving the colon in severe colitis - the case for medical therapy. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16961749
|
Schmidt KJ et al. |
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23121200
|
Romano C et al. |
Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20148798
|
McSharry K et al. |
Systematic review: the role of tacrolimus in the management of Crohn's disease. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21999607
|
Itoh S et al. |
Inhibition of CN (protein phosphatase-2B) suppresses Ca2+-mediated acid secretion in rats. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966520
|
Yamamoto S et al. |
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18549460
|
O'Leary JG |
Editorial: tacrolimus-how low can you go? |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589579
|
Beckebaum S et al. |
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. |
2009 |
Aliment. Pharmacol. Ther. |
pmid:19624550
|
Firpi RJ et al. |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113371
|
Herrlinger KR et al. |
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20175769
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Hisanaga Y et al. |
Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971291
|
Schwrer H et al. |
Pantoprazole and cyclosporine or tacrolimus. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11284790
|
Högenauer C et al. |
Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12940927
|
Trotter JF et al. |
Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15963078
|
Nakase H et al. |
Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-α therapy. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21434949
|
Nakase H et al. |
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis? |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21198700
|
Yamamoto T et al. |
Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137731
|
Laharie D and Poullenot F |
Letter: which patient profile for tacrolimus in ulcerative colitis? |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27137730
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|
Lawrance IC and Copeland TS |
Rectal tacrolimus in the treatment of resistant ulcerative proctitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18761706
|
Liberal R et al. |
Expert clinical management of autoimmune hepatitis in the real world. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28004405
|
Segal JP et al. |
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28008631
|
Mehta SJ et al. |
Review article: strategies for the management of chronic unremitting ulcerative colitis. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23718288
|
Yamamoto T et al. |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040167
|
Taylor KM and Sparrow MP |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040166
|
Haagsma EB et al. |
Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12848624
|
Nakase H et al. |
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20636704
|
Ortiz de Frutos FJ |
[New horizons in the treatment of atopic dermatitis]. |
|
Allergol Immunopathol (Madr) |
pmid:11988144
|
Mori F et al. |
Increase of natural killer cells in children with liver transplantation-acquired food allergy. |
|
Allergol Immunopathol (Madr) |
pmid:29456038
|
Regueiro-GarcÃa A et al. |
Haploidentical stem cell transplantation in a boy with chronic granulomatous disease. |
|
Allergol Immunopathol (Madr) |
pmid:29373243
|
Inoue Y et al. |
Food allergy after cord blood stem cell transplantation with tacrolimus therapy in two patients who developed veno-occlusive disease. |
2012 |
Allergol Int |
pmid:22722810
|
Tsuji T et al. |
Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice. |
2016 |
Allergol Int |
pmid:26666476
|
Miyachi Y et al. |
Suplatast/tacrolimus combination therapy for refractory facial erythema in adult patients with atopic dermatitis: a meta-analysis study. |
2007 |
Allergol Int |
pmid:17582208
|
Ebihara N et al. |
Blood level of tacrolimus in patients with severe allergic conjunctivitis treated by 0.1% tacrolimus ophthalmic suspension. |
2012 |
Allergol Int |
pmid:22361511
|
Yamamoto M et al. |
A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. |
2007 |
Allergol Int |
pmid:17460441
|
Wollenberg A et al. |
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. |
2008 |
Allergy |
pmid:18445188
|
Jensen JM et al. |
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. |
2012 |
Allergy |
pmid:22142306
|
Bieber T et al. |
Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. |
2007 |
Allergy |
pmid:17298428
|
Wollenberg A et al. |
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. |
2008 |
Allergy |
pmid:18592619
|
Bergstrand H and Lundquist B |
Human basophil histamine release is differently affected by inhibitors of calmodulin, diacylglycerol kinase and peptidyl prolyl cis-trans isomerase in a secretagogue specific manner. |
1992 |
Allergy |
pmid:1280915
|
Kaufmann R et al. |
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. |
2006 |
Allergy |
pmid:16436149
|
Oldhoff JM et al. |
Modulation of the atopy patch test: tacrolimus 0.1% compared with triamcinolone acetonide 0.1%. |
2006 |
Allergy |
pmid:16629794
|
Simon D et al. |
Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. |
2005 |
Allergy |
pmid:15932386
|
Leonardi S et al. |
Efficacy and safety of tacrolimus ointment 0.03% treatment in a 1-month-old "red baby": a case report. |
2006 Nov-Dec |
Allergy Asthma Proc |
pmid:17176789
|
Pacor ML et al. |
Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis. |
2006 Nov-Dec |
Allergy Asthma Proc |
pmid:17176790
|
Rico MJ and Lawrence I |
Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects. |
2002 May-Jun |
Allergy Asthma Proc |
pmid:12125507
|
Szema AM |
Angioedema in a child with a liver transplant, intussusception, and normal c4 levels. |
2010 Jul-Aug |
Allergy Asthma Proc |
pmid:20615276
|
Kay AB |
Immunosuppressive agents in chronic severe asthma. |
1994 May-Jun |
Allergy Proc |
pmid:7523242
|
Wilhelmi E et al. |
Organotypic brain-slice cultures from adult rats: approaches for a prolonged culture time. |
2002 May-Jun |
Altern Lab Anim |
pmid:12106005
|
Mcauliffe EP |
Is tacrolimus the best therapy for atopic dermatitis? |
2003 |
Am Fam Physician |
pmid:12751651
|
Lane JE and Johnson J |
Persistent penile patch. |
2008 |
Am Fam Physician |
pmid:19007056
|
Russell JJ |
Topical tacrolimus: a new therapy for atopic dermatitis. |
2002 |
Am Fam Physician |
pmid:12469964
|
Berke R et al. |
Atopic dermatitis: an overview. |
2012 |
Am Fam Physician |
pmid:22962911
|
Hitzeman N and Kinnevey C |
Topical Tacrolimus for Eczema. |
2016 |
Am Fam Physician |
pmid:27929217
|
Baran DA et al. |
Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment. |
2004 |
Am J Cardiovasc Drugs |
pmid:14967063
|
Ramirez R et al. |
Posterior Reversible Encephalopathy Syndrome After Orthotopic Heart Transplantation: A Case Report. |
2017 |
Am J Case Rep |
pmid:28465499
|
Kawamura H et al. |
Rapid Induction Therapy with Oral Tacrolimus in Elderly Patients with Refractory Ulcerative Colitis Can Easily Lead to Elevated Tacrolimus Concentrations in Blood: A Report of 5 Cases. |
2017 |
Am J Case Rep |
pmid:28411286
|
Udomkarnjananun S et al. |
An Unusual Manifestation of Calcineurin Inhibitor-Induced Pain Syndrome in Kidney Transplantation: A Case Report and Literature Review. |
2018 |
Am J Case Rep |
pmid:29654227
|
Gupta AK and Versteeg SG |
Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review. |
2017 |
Am J Clin Dermatol |
pmid:27804089
|
Kroft EB et al. |
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. |
2009 |
Am J Clin Dermatol |
pmid:19354332
|
Lübbe J et al. |
Safety, efficacy, and dosage of 1% pimecrolimus cream for the treatment of atopic dermatitis in daily practice. |
2006 |
Am J Clin Dermatol |
pmid:16605292
|